Verdant Life Sciences
Verdant Life Sciences, also known as Verdant Pharma, is a leading player in the pharmaceutical industry, headquartered in India. Established in 2016, the company has rapidly expanded its operations across key regions, focusing on the development and manufacturing of high-quality generic medicines. Specialising in complex generics and niche therapeutic areas, Verdant Life Sciences distinguishes itself through its commitment to innovation and quality. The company’s core offerings include a diverse range of injectable and oral dosage forms, designed to meet the evolving needs of healthcare providers and patients alike. With a strong market position, Verdant Life Sciences has achieved significant milestones, including regulatory approvals from major global health authorities. This dedication to excellence has solidified its reputation as a trusted partner in the pharmaceutical landscape.
DitchCarbon Score
How does Verdant Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Verdant Life Sciences's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Verdant Life Sciences's reported carbon emissions
Verdant Life Sciences, headquartered in India, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. Verdant Life Sciences may benefit from adopting industry-standard practices, such as establishing Science-Based Targets Initiative (SBTi) commitments, to enhance their climate strategy and transparency. As the global emphasis on climate action intensifies, it is crucial for companies like Verdant Life Sciences to develop and communicate clear emissions reduction strategies to align with best practices and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Verdant Life Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
